|Articles|February 1, 2006

Psychiatric Issues in Emergency Care Settings

  • Psychiatric Issues in Emergency Care Settings Vol 5 No 1
  • Volume 5
  • Issue 1

Evaluating for Alcohol and Substance AbuseAlcohol and Drug Abuse Intervention in the Emergency Department: A Step Toward RecoverySubstance Use Disorders in the Emergency SettingDual Diagnosis: A Challenge for ED Clinicians

Editorial

LESLIE S. ZUN, MD, MBA

Patient Assessment

MARCELLO A. MAVIGLIA, MD, MPH

Clinical Case Presentations

MARCELLO A. MAVIGLIA, MD, MPH

Commentary

PETER F. BUCKLEY, MD

also inside: Literature Highlights, Reader Forum, Meeting Calendar

Articles in this issue

almost 20 years ago

Back Issues Available

almost 20 years ago

Psychiatric Price of Steroid Abuse

almost 20 years ago

ADD THE BLACK BOX TO MORE LABELS?

almost 20 years ago

PSYCHIATRIC SYMPTOMS SIGNAL AUTOIMMUNE DISORDERS

almost 20 years ago

DECADE OF DISCOVERY IN PEDIATRIC BD

almost 20 years ago

Evaluating for Alcohol and Substance Abuse

almost 20 years ago

Can you give our staff some guidance on the appropriate use of critical incident stress debriefing and psychological first aid?

almost 20 years ago

Are benzodiazepines appropriate to prescribe for survivors and others after an incidence of mass trauma?

almost 20 years ago

Dual Diagnosis: A Challenge for ED Clinicians

almost 20 years ago

Substance Use Disorders in the Emergency Setting

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Latest CME

Real Psychiatry 2026
In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

View more
Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?
Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

View more
Optimizing Care for Patients With Tardive Dyskinesia
Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

View more
Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia
Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

View more
(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more
(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia
Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

View more
Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder
Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

View more
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us